A coalition of 13 lithium producers behind key Strategic Projects under the EU’s Critical Raw Materials Act (CRMA) has issued a joint letter to the European Commission, warning that the proposed classification of lithium salts as Category 1A reproductive toxins could undermine Europe’s climate and industrial ambitions.
The group, which includes developers of some of the continent’s most advanced lithium initiatives, expressed deep concern that the move by the European Chemicals Agency (ECHA) conflicts directly with the bloc’s Green Deal, net-zero goals, and push for strategic autonomy.
According to the letter, the reclassification would shake investor confidence, delay CRMA-aligned projects, weaken Europe’s position in the global battery value chain, and create contradictory policy signals.
They call on the Commission to ensure that regulatory decisions remain science-based, proportionate to real risk, and do not threaten Europe’s strategic aims. The producers argue that a supportive regulatory framework is critical to delivering both the green and digital transitions.
